"Pharmaceutical companies have made tremendous progress in terms of patient engagement, and the same actually goes for their relationships with NGOs and patient organizations."
In Conversation
"Merck has implemented a number of initiatives to deter drug counterfeiting in addition to opening rural pharmacies in Africa."
"We are currently in the process of moving from our older genericised portfolio to our newer assets which we have launched during the last four years."
"We must focus heavily on legislation and the amendments made to the reimbursement act in regard to ensuring the payback system is acceptable from an industry…
"Overall, I deeply believe that Brazil’s health system should evolve so we could pride on the healthcare quality that our citizens are able to access, whether…
"Brazil indeed stands as one of the only two countries in the world – alongside Turkey – where Amgen holds a substantial presence in the generics…
"We became a member of the EuDRAcon in 2010 and this partnership has given us the opportunity to participate in pan-European projects in joint with its…
"Tunisia has both, laboratories of innovative MNCs operating in the country as well as local production, solely composed of generics."
"SIPHAT will remain true to its main purpose, being a support institution to the state in its healthcare policies."
"Boukhari Prince Medical has succeeded in finding the right balance between high levels of quality and a competitive rate for its customers."
"I believe that Bulgaria has the potential to host more global functions for Teva and thus to contribute to the future success of our company providing…
"We are looking forward to reinforcing our portfolio of products with innovative molecules in promising therapeutic areas or niche markets."
